Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Relapse and drug resistance gene mutation detection kit and application method of acute lymphoblastic leukemia

An acute lymphocyte detection kit technology, applied in biochemical equipment and methods, microbial determination/inspection, etc., can solve problems affecting clinical prognosis, promote disease recurrence, etc., achieve strong applicability, reduce false positives, and detect Clear and clear results

Active Publication Date: 2022-03-15
北京海思特医学检验实验室有限公司
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Related studies have pointed out that the high expression and mutation of cN-II are related to the drug resistance of cytarabine (Ara-c) and 6-mercaptopurine (6-MP), which promotes disease recurrence and affects the clinical prognosis of ALL.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Relapse and drug resistance gene mutation detection kit and application method of acute lymphoblastic leukemia
  • Relapse and drug resistance gene mutation detection kit and application method of acute lymphoblastic leukemia
  • Relapse and drug resistance gene mutation detection kit and application method of acute lymphoblastic leukemia

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0045] Composition and preparation of embodiment 1 kit

[0046] In the present invention, for acute lymphoblastic leukemia chemotherapy resistance and relapse-related NT5C2 drug resistance gene, a detection kit and application method for acute lymphoblastic leukemia treatment medication and close detection of relapse are developed. This gene is currently the most promising target for the detection of chemotherapy resistance and relapse of acute lymphoblastic leukemia, and can play an important role in the current and future treatment of acute lymphoblastic leukemia.

[0047] The source of the gene sequence detected by the present invention is the NCBI (National Center for Biotechnology Information) gene bank, and the specific identification and functions are shown in Table 1 below:

[0048] Table 1

[0049]

[0050] The domain distribution diagram of the gene-encoded protein detected by the present invention, such as figure 1 shown.

[0051] The invention provides a kit ...

Embodiment 2

[0061] Example 2 Detection and verification report of the kit

[0062] 1. Name of the test procedure (method) of the acute lymphoblastic leukemia drug detection and recurrence monitoring kit of the present invention: NT5C2 gene mutation detection (PCR-generation sequencing method).

[0063] 2. The purpose of verification: through the analysis and evaluation of the accuracy, sensitivity, and precision of the methodology, the method verification of the testing procedure (methodology) is carried out to meet the needs of clinical experiments.

[0064] 3. Experimental materials:

[0065] 3.1. Specimen type: DNA extracted from peripheral blood.

[0066] 3.2. Reagents: This verification experiment uses the conventional reagents of the molecular platform, and all reagents are within the validity period. The main reagent information is shown in Table 4:

[0067] Table 4 Reagent information used for NT5C2-related gene mutation detection verification

[0068]

[0069] 3.3. Instrume...

Embodiment approach

[0082] The specific implementation is as follows:

[0083] In step S1, peripheral blood is used as the sample to be tested. Genomic DNA can be extracted using a conventional kit column extraction method, and operated according to the instructions of the kit used to collect 50 μL of DNA solution with a concentration of 50-200 ng / μL, which can be directly used Before testing or store at -20°C;

[0084] The verification experiment used 7 specimens, and the specimen type was DNA extracted from peripheral blood. See Table 5 for the specimens.

[0085] Table 5. Specimen information used for NT5C2-related gene mutation detection verification

[0086] sample name sample type sample number 1 DNA extracted from peripheral blood p16060306 2 DNA extracted from peripheral blood p16060608 3 DNA extracted from peripheral blood p16061215 4 DNA extracted from peripheral blood p16061242 5 DNA extracted from peripheral blood p16061548 6 DN...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the field of medicine and molecular detection, and specifically relates to a detection kit and application method for acute lymphoblastic leukemia (ALL) recurrence and drug-resistant gene mutation. The detection kit of the present invention includes targeting NT5C2 Specific primers for gene mutation sites can be used for NT5C2 Comprehensive and accurate detection of highly mutated sites in the gene, the detection results have strong clinical guiding significance, and can be used for rapid and accurate detection of acute lymphoblastic leukemia (ALL) recurrence and drug resistance, avoiding unnecessary treatment drugs, and in acute lymphoblastic leukemia (ALL) The field of detection and treatment of lymphocytic leukemia is of great significance. The present invention by the ALL recurrence, drug resistance related NT5C2 Gene mutation detection can better guide clinicians in medication and treatment, and can be used as an auxiliary means for the diagnosis of relapsed drug resistance of the disease.

Description

technical field [0001] The invention belongs to the field of medicine and molecular detection, and specifically relates to a detection kit and application method for acute lymphoblastic leukemia (ALL) recurrence and drug-resistant gene mutation. Background technique [0002] Acute lymphoblastic leukemia (ALL) is a malignant tumor that originates from the abnormal proliferation of B-lineage or T-lineage blast cells of lymphocytes in the bone marrow. Abnormally proliferating blast cells can gather in the bone marrow and inhibit normal hematopoietic function, and can also invade other tissues outside the bone marrow, such as meninges, lymph nodes, gonads, liver, and bones. Bone marrow (BM) is involved in all ALL patients, peripheral blood (PB) is often involved in B-ALL, but T-ALL is more common. Involvement of extramedullary sites such as the central nervous system, lymph nodes, liver, spleen, and testes in men is also common. Clinically, dizziness, fatigue, palpitation, sho...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12Q1/6886
CPCC12Q1/6886C12Q2600/106C12Q2600/118C12Q2600/156
Inventor 傅廷娇张娟程宇梁超王绪华陈忠黄士昂
Owner 北京海思特医学检验实验室有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com